Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2026-02-01 @ 4:26 PM
Study NCT ID:
NCT05604560
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-07-23
First Post:
2022-10-28
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer
Sponsor:
Organization: